firdapse(amifampridine phosphate)Medication DetailsCatalyst Pharmaceuticals, Inc.Usage: FIRDAPSE® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients aged 6 years and older.Medication DetailsDrug Interactions